“…Reports of NMU persist in the scientific literature and in the popular press (Arria et al, 2011; Faraone et al, 2020; Friedman, 2010; Garnier-Dykstra et al, 2012; Italiano, 2011; McCabe & West, 2013; McCabe et al, 2004, 2005, 2006b, 2009; Peltz, 2012; Pratt-Kielley, 2020; Schepis, Ford et al, 2020; Schepis, Klare et al, 2020; Swanson & Volkow, 2008; Wilens et al, 2020). Prescription stimulant NMU has been associated with a number of risks that have been epidemiologically reported including behavioral risks such as possible off-label use (Burcu et al, 2016), diversion (Compton et al, 2018; Han et al, 2017), or dating violence (Whiteside et al, 2015), health risks such as aortic dissection (Westover & Nakonezny, 2010), acute myocardial infarction (Westover et al, 2008), or psychiatric disorders (Wilens et al, 2020) among others (Faraone et al, 2019, 2020). While the existence of non-oral NMU is well-documented, details surrounding use with specific routes of administration (ROAs) are less well understood.…”